TMDX Q2 2021 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+141.0% YoY

Gross Profit

$6M68.4% margin

Operating Income

-$10M-120.8% margin

Net Income

-$11M-130.6% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+15.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$141M

Total Liabilities

$52M

Stockholders' Equity

$89M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$3M	+141.0%
Gross Profit	$6M	$2M	+192.8%
Operating Income	-$10M	-$8M	-25.5%
Net Income	-$11M	-$8M	-25.6%

Revenue Segments

Ocs Heart Product

$5M56%

Ocs Lung Product

$4M44%

Geographic Segments

UNITED STATES

$6M81%

Non Us And Uk

$1M19%